Abstract
The aim of this study was to determine the significance of bone scan findings in Korean polymyositis/dermatomyositis (PM/DM) patients. The participants in this study were 26 PM/DM patients who fulfilled the proposed criteria for definite or probable PM/DM. All patients had been examined by bone scan. The results were analyzed visually and quantitatively using the uptake ratios. Correlations between the bone scan parameters of six proximal muscle groups (trapezius, deltoid, biceps, iliopsoas, quadriceps, and gluteus medius and maximus) and clinical parameters (laboratory values and manual muscle test) representing disease activities were assessed. Based on visual analyses of their bone scans, 10 of 14 (71.4 %) patients with active PM/DM had abnormal muscle uptake. Visual grading of the bone scans had a sensitivity and specificity of 74 and 90.9 %, respectively, for the assessment of muscle inflammation. Maximal proximal muscle uptake ratios, as determined on the bone scans, were significantly higher in patients with active PM/DM than in those with inactive disease (median 1.97 vs. 1.02, p = 0.046). Maximal proximal uptake ratios correlated significantly with creatine kinase (r = 0.394, p = 0.046), lactate dehydrogenase (LDH, r = 0.473, p = 0.015), aldolase (r = 0.428, p = 0.029), erythrocyte sedimentation rate (r = 0.412, p = 0.036), C-reactive protein (r = 0.454, p = 0.002), and manual muscle test results (r = −0.399, p = 0.044). Mean proximal muscle uptake ratios correlated significantly with LDH (r = 0.438, p = 0.025) and aldolase (r = 0.572, p = 0.002). Visually assessed proximal muscle uptake grades and maximal proximal muscle uptake ratios as determined by bone scan correlated significantly with the levels of known PM/DM disease activity markers. The findings of this study suggest that bone scan is a useful imaging technique for the evaluation of PM/DM patients.
Similar content being viewed by others
References
Carstens PO, Schmidt J (2014) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol 175:349–358
Nasr R, Reed AM, Peterson EJ (2012) Update: biomarkers for idiopathic inflammatory myopathies. Curr Opin Rheumatol 24:609–615
Fraser DD, Frank JA, Dalakas M et al (1991) Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 18:1693–1700
Pitt AM, Fleckenstein JL, Greenlee RG Jr et al (1993) MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 11:1093–1099
Tomasova Studynkova J, Charvat F, Jarosova K, Vencovsky J (2007) The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford) 46:1174–1179
Tanaka S, Ikeda K, Uchiyama K et al (2013) [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford) 52:1271–1278
Owada T, Maezawa R, Kurasawa K et al (2012) Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 39:1659–1665
Pipitone N, Versari A, Zuccoli G et al (2012) 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol 30:570–573
Lazarou IN, Guerne PA (2013) Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol 40:550–564
Brill DR (1981) Radionuclide imaging of nonneoplastic soft tissue disorders. Semin Nucl Med 11:277–288
Goldfarb CR, Ongseng F, Kuhn M, Metzger T (1988) Non-skeletal accumulation of bone seeking agents: pelvis. Semin Nucl Med 18:159–161
Brown M, Swift TR, Spies SM (1976) Radioisotope scanning in inflammatory muscle disease. Neurology 26:517–520
Scott JA, Palmer EL, Fischman AJ (1989) HIV-associated myositis detected by radionuclide bone scanning. J Nucl Med 30:556–558
Spies SM, Swift TR, Brown M (1975) Increased 99mTc-polyphosphate muscle uptake in a patient with polymyositis: case report. J Nucl Med 16:1125–1127
Wu Y, Seto H, Shimizu M et al (1996) Extensive soft-tissue involvement of dermatomyositis detected by whole-body scintigraphy with 99mTc-MDP and 201TL-chloride. Ann Nucl Med 10:127–130
Mitomo M, Miyazaki C, Mukai M et al (2005) Tc-99m MDP bone scintigraphy of myositis as a manifestation of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation. Ann Nucl Med 19:41–45
Otsuka N, Fukunaga M, Ono S et al (1988) Visualization of soft tissue by technetium-99m MDP in polymyositis. Case reports. Clin Nucl Med 13:291–293
Walker UA, Garve K, Brink I et al (2007) 99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease. Clin Rheumatol 26:1119–1122
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407
Harris-Love MO, Shrader JA, Koziol D et al (2009) Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) 48:134–139
Rider LG, Koziol D, Giannini EH et al (2010) Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 62:465–472
Kendall FME, Provance P et al (2005) Muscles: testing and function, 5th edn. Williams & Wilkins, Baltimore
Tzaribachev N, Well C, Schedel J, Horger M (2009) Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatol Int 29:1511–1514
Weckbach S (2009) Whole-body MR imaging for patients with rheumatism. Eur J Radiol 70:431–441
Malattia C, Damasio MB, Madeo A et al. (2013) Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis
Walker UA (2008) Imaging tools for the clinical assessment of idiopathic inflammatory myositis. Curr Opin Rheumatol 20:656–661
Weber MA, Krakowski-Roosen H, Delorme S et al (2006) Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. J Ultrasound Med 25:583–591
Krix M, Weber MA, Krakowski-Roosen H et al (2005) Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography. J Ultrasound Med 24:431–441
Weber MA, Jappe U, Essig M et al (2006) Contrast-enhanced ultrasound in dermatomyositis- and polymyositis. J Neurol 253:1625–1632
Abdullah ZS, Khan MU, Kodali SK, Javaid A (2010) Pyomyositis mimicking osteomyelitis detected by SPET/CT. Hell J Nucl Med 13:277–279
Ortapamuk H (2004) Myopathy associated with primary biliary cirrhosis demonstrating muscle involvement on bone scanning. Clin Nucl Med 29:725–726
Yonker RA, Webster EM, Edwards NL et al (1987) Technetium pyrophosphate muscle scans in inflammatory muscle disease. Br J Rheumatol 26:267–269
von Kempis J, Kalden P, Gutfleisch J et al (1998) Diagnosis of idiopathic myositis: value of 99mtechnetium pyrophosphate muscle scintigraphy and magnetic resonance imaging in targeted muscle biopsy. Rheumatol Int 17:207–213
Siegel BA, Engel WK, Derrer EC (1977) Localization of technetium-99m diphosphonate in acutely injured muscle. Relationship to muscle calcium deposition. Neurology 27:230–238
Vita G, Harris JB (1981) The uptake of 99mtechnetium diphosphonate into degenerating and regenerating muscle. A correlative histological and biochemical study. J Neurol Sci 51:339–354
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
An, YS., Suh, CH., Jung, JY. et al. Role of bone scan in the assessment of polymyositis/dermatomyositis. Clin Rheumatol 34, 699–706 (2015). https://doi.org/10.1007/s10067-014-2837-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2837-2